1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Sickle Cell Disease Regional Care Excellence (SoRCE) Program" is currently closed and not accepting applications.
Sickle Cell Disease Regional Care Excellence (SoRCE) Program is sponsored by Health Resources and Services Administration. Sickle Cell Disease Regional Care Excellence Program (SoRCE) is to improve the health of people with sickle cell disease (SCD) by expanding access to care, improving the quality of care, and tracking quality of life indicators.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Sickle Cell Disease Regional Care Excellence (SoRCE) Program Department of Health and Human Services Health Resources and Services Administration Document Type:Grants Notice Funding Opportunity Number:HRSA-26-052 Funding Opportunity Title:Sickle Cell Disease Regional Care Excellence (SoRCE) Program Opportunity Category:Discretionary Opportunity Category Explanation: Funding Instrument Type:Cooperative Agreement Category of Funding Activity:Health Expected Number of Awards:7 Assistance Listings:93.
365 -- Sickle Cell Treatment Demonstration Program Cost Sharing or Matching Requirement:No Last Updated Date:Jun 05, 2026 Original Closing Date for Applications:Jul 08, 2026 Electronically submitted applications must be submitted no later than 11:59 p. m. , ET, on the listed application due date.
Current Closing Date for Applications:Jul 08, 2026 Electronically submitted applications must be submitted no later than 11:59 p. m. , ET, on the listed application due date.
Archive Date:Aug 30, 2026 Estimated Total Program Funding:$ 6,650,000 Eligible Applicants:Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Private institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Additional Information on Eligibility:Hospitals or clinicsHealth centers.
## Additional Information Agency Name:Health Resources and Services Administration Description:Sickle Cell Disease Regional Care Excellence Program (SoRCE) is to improve the health of people with sickle cell disease (SCD) by expanding access to care, improving the quality of care, and tracking quality of life indicators. There are approximately 100,000 people in the United States with SCD.
Treatment starting in early childhood can prevent or reduce complications such as severe pain episodes, silent strokes, and premature death. Despite universal identification at birth, fewer than half of children with SCD receive needed treatment.
As these children become adolescents and transition to adulthood many are not appropriately identified as candidates for disease-modifying therapies, in part because their doctors are still learning how to use the latest treatments. The program is made up of seven regions with one award recipient per region serving as a Regional Coordinating Hub (RCH).
Each award recipient will work with clinical and community-based partners in their region and engage in continuous quality improvement (CQI) initiatives to improve access and quality of care. Link to Additional Information:[](https://www. grants.
gov/search-results-detail/360997) Grantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact: ## Similar Opportunities (identified by AI)
According to the current listing, eligibility includes: Eligible applicants: Public and State controlled institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits that do not have a 501(c)(3) …. Confirm the full requirements in the official notice before applying.
The current listing shows up to $950K per award. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was July 8, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Yes — Sickle Cell Disease Regional Care Excellence (SoRCE) Program is offered by Health Resources and Services Administration and this listing comes from Grants.gov, an official U.S. federal source. Federal applications generally require registrations (for example SAM.gov or an agency submission portal), so allow extra lead time.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
HRSA-27-006 and HRSA-27-007 post September 18, 2026 and both close October 19 — $711.4 million across 189 awards for service areas that already have a health center in them. The incumbent is defending. Everyone else is holding a free option.
Read articleHRSA-27-099 offers $125 million for 357 awards of $350,000 each to health centers with an active H80 award, closing September 9, 2026. An identical FY2026 round closed June 9 with the same money, the same award count, and a September 1 award date. Here is what back-to-back rounds mean for winners and losers of the first one, and why the 120-day implementation clause is the real commitment.
Read articleOn September 4, 2026, HRSA awarded $11.2 million through the Rural Residency Planning and Development program to build 15 new physician residencies across 14 states. Since 2019 the program has invested nearly $77 million, producing 66 accredited programs and 818 approved positions. Here is what the conversion rate reveals, why the specialty mix is narrowing, and how to build a competitive application for the next cycle.
Read article